Jan 12 (Reuters) - Novartis will continue to do
bolt-on deals and its capital allocation priorities remain
unchanged, CEO Vasant Narasimhan said at a major industry
conference that kicked off Monday in San Francisco.
(Reporting by Sneha S K in Bengaluru and Maggie Fick)